Cargando…
Rapid regression of choroidal metastasis from lung cancer using erlotinib (Tarceva)
Lung carcinoma is the leading cause of cancer-related deaths and is the primary source for choroidal metastasis in over 20% cases. Non-small-cell lung cancer (NSCLC) accounts for 85% of all lung cancer cases. Patients with metastatic NSCLC have a median survival of one year. Successful treatment of...
Autores principales: | Ye, Xuemei, Kaliki, Swathi, Shields, Carol L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134551/ https://www.ncbi.nlm.nih.gov/pubmed/25136232 http://dx.doi.org/10.4103/0974-620X.137159 |
Ejemplares similares
-
Acneiform rash during lung cancer therapy with erlotinib (Tarceva(®))
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2013) -
Choroidal metastasis from leiomyosarcoma in two cases
por: Feinstein, Eric, et al.
Publicado: (2014) -
Cystoid macular edema as the initial manifestation of choroidal melanoma
por: Garoon, Robert B., et al.
Publicado: (2012) -
Choroidal metastases: Origin, features, and therapy
por: Arepalli, Sruthi, et al.
Publicado: (2015) -
The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metastatic renal cell carcinoma: the role of a synonymous mutation of the EGFR receptor
por: Grépin, Renaud, et al.
Publicado: (2020)